ES2159022T3 - Dispositivo autonomo de administracion por via transdermica. - Google Patents

Dispositivo autonomo de administracion por via transdermica.

Info

Publication number
ES2159022T3
ES2159022T3 ES96910394T ES96910394T ES2159022T3 ES 2159022 T3 ES2159022 T3 ES 2159022T3 ES 96910394 T ES96910394 T ES 96910394T ES 96910394 T ES96910394 T ES 96910394T ES 2159022 T3 ES2159022 T3 ES 2159022T3
Authority
ES
Spain
Prior art keywords
transdermica
device via
administration device
medically
autonomous administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96910394T
Other languages
English (en)
Inventor
Gary A Lattin
Tighe M Belden
Andrew J Withell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2159022T3 publication Critical patent/ES2159022T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

SE EXPONE UN METODO PARA FABRICAR UN DISPOSITIVO PARA ADMINISTRACION DE MEDICAMENTO A TRAVES DE LA PIEL (10), EN DONDE UN COMPONENTE (32) Y/O UN MONTAJE PARCIAL (20), SE ADAPTAN A PROPOSITO PARA SER SEPARABLES DEL RESTO DEL DISPOSITIVO DE DISTRIBUCION, QUE ES MAS ACEPTABLE MEDICA O MEDIO AMBIENTALMENTE. EN UNA REALIZACION DE LA INVENCION, EL DISPOSITIVO (10) COMPRENDE CARCASAS SUPERIOR E INFERIOR (16, 20), SIENDO SEPARABLE LA CARCASA INFERIOR (20) DE LA CARCASA SUPERIOR (16) Y PLEGABLE SOBRE SI MISMA, PARA MINIMIZAR UN CONTACTO INACEPTABLE MEDICAMENTE CON, P. EJ., UN DEPOSITO DE MEDICAMENTO (26 O 28) CONTENIDO EN SU INTERIOR. SE INCLUYE UN DISPOSITIVO (10) REALIZADO DE ACUERDO CON LA INVENCION.
ES96910394T 1995-03-24 1996-03-08 Dispositivo autonomo de administracion por via transdermica. Expired - Lifetime ES2159022T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/410,203 US5879322A (en) 1995-03-24 1995-03-24 Self-contained transdermal drug delivery device

Publications (1)

Publication Number Publication Date
ES2159022T3 true ES2159022T3 (es) 2001-09-16

Family

ID=23623707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96910394T Expired - Lifetime ES2159022T3 (es) 1995-03-24 1996-03-08 Dispositivo autonomo de administracion por via transdermica.

Country Status (11)

Country Link
US (1) US5879322A (es)
EP (1) EP0817659B1 (es)
JP (1) JPH11503037A (es)
AT (1) ATE201604T1 (es)
DE (1) DE69613113T2 (es)
DK (1) DK0817659T3 (es)
ES (1) ES2159022T3 (es)
GR (1) GR3036450T3 (es)
PT (1) PT817659E (es)
WO (1) WO1996030077A1 (es)
ZA (1) ZA962122B (es)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
IE960375A1 (en) * 1995-06-05 1996-12-11 Alza Corp Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
US6157858A (en) * 1996-12-26 2000-12-05 Elan Pharma International Limited Device for the delivery of a substance to a subject and improved electrode assembly
AU5337998A (en) * 1996-12-26 1998-07-31 Elan International Services Limited Device for the delivery of a substance to a subject and improved electrode assembly
US5991655A (en) * 1997-03-03 1999-11-23 Drug Delivery Systems, Inc. Iontophoretic drug delivery device and method of manufacturing the same
US8177762B2 (en) 1998-12-07 2012-05-15 C. R. Bard, Inc. Septum including at least one identifiable feature, access ports including same, and related methods
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
DE60036863T2 (de) * 1999-03-25 2008-07-31 Metabolix, Inc., Cambridge Medizinische vorrichtungen und verwendungen von polyhydroxyalkanoatpolymeren
EP1212046A2 (en) 1999-08-30 2002-06-12 Tepha, Inc. Flushable disposable polymeric products
US20010041869A1 (en) * 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
EP1317306B1 (en) * 2000-09-11 2005-04-20 Alza Corporation Transdermal electrotransport device and method for manufacturing same
US7010343B2 (en) * 2001-04-06 2006-03-07 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7496401B2 (en) * 2001-04-06 2009-02-24 Mattioli Engineering Ltd Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7083580B2 (en) * 2001-04-06 2006-08-01 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US7520875B2 (en) * 2001-04-06 2009-04-21 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US8574204B2 (en) * 2002-10-21 2013-11-05 Angiodynamics, Inc. Implantable medical device for improved placement and adherence in the body
EP1638615B1 (en) 2003-05-08 2014-10-29 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
EP1651273B1 (en) * 2003-07-08 2012-08-29 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20050038473A1 (en) * 2003-07-14 2005-02-17 Dov Tamarkin Device and method for the treatment of pilosebaceous disorders
AU2004268560B2 (en) * 2003-08-22 2008-08-21 Tepha, Inc. Polyhydroxyalkanoate nerve regeneration devices
US20050065062A1 (en) * 2003-09-24 2005-03-24 3M Innovative Properties Company Method of formulating a pharmaceutical composition
ES2336214T3 (es) 2003-10-27 2010-04-09 Universitat Basel Sistema de suministro transdermico de farmacos.
US20070191815A1 (en) * 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US8366687B2 (en) 2004-01-06 2013-02-05 Angio Dynamics Injection access port with chamfered top hat septum design
US20050271597A1 (en) * 2004-02-13 2005-12-08 Keith Alec D Prostate hypertrophy treatment composition and method
US8277425B2 (en) 2004-03-24 2012-10-02 Navilyst Medical, Inc. Dual lumen port with F-shaped connector
ES2362217T3 (es) * 2004-08-03 2011-06-29 Tepha, Inc. Suturas de polihidroxialcanoato no rizadas.
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
ATE481088T1 (de) * 2005-01-28 2010-10-15 Tepha Inc Embolisierung unter verwendung von poly-4- hydroxybutyrat-partikeln
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
WO2006096686A1 (en) 2005-03-04 2006-09-14 C.R. Bard, Inc. Access port identification systems and methods
US8029482B2 (en) 2005-03-04 2011-10-04 C. R. Bard, Inc. Systems and methods for radiographically identifying an access port
US7947022B2 (en) 2005-03-04 2011-05-24 C. R. Bard, Inc. Access port identification systems and methods
US8386029B2 (en) 2005-03-31 2013-02-26 Encore Medical Asset Corporation Apparatus for electrotherapy drug delivery with added impurities
EP1874393B1 (en) 2005-04-27 2017-09-06 C.R.Bard, Inc. Infusion apparatuses
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
EP2308547B1 (en) * 2005-04-27 2014-09-17 C.R. Bard, Inc. High pressure access port with septum
US8372040B2 (en) 2005-05-24 2013-02-12 Chrono Therapeutics, Inc. Portable drug delivery device including a detachable and replaceable administration or dosing element
US8287923B2 (en) * 2005-06-10 2012-10-16 Medical College Of Georgia Research Institute, Inc. Compositions and methods for treating immune disorders
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US9550050B2 (en) * 2006-09-25 2017-01-24 MEDIMETRICS Personalized Drug Delivery B.V. Medicament delivery apparatus
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US9265912B2 (en) 2006-11-08 2016-02-23 C. R. Bard, Inc. Indicia informative of characteristics of insertable medical devices
US7943683B2 (en) * 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US20100041704A1 (en) * 2007-01-12 2010-02-18 Aberg A K Gunnar Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
US8197844B2 (en) * 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US8738137B2 (en) 2007-08-23 2014-05-27 Bioness Inc. System for transmitting electrical current to a bodily tissue
EP2180918B1 (en) * 2007-08-23 2017-07-12 Bioness Inc. Electrodes with a power source and with connectors for coupling to an external stimulator
US9757554B2 (en) 2007-08-23 2017-09-12 Bioness Inc. System for transmitting electrical current to a bodily tissue
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US8075536B2 (en) * 2008-09-09 2011-12-13 Navilyst Medical, Inc. Power injectable port identification
BRPI0919890B8 (pt) 2008-10-31 2019-09-24 Bard Inc C R orifício de acesso para prover acesso subcutâneo a um paciente, e, orifício de acesso injetável de força
US8932271B2 (en) 2008-11-13 2015-01-13 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
BRPI0923808A2 (pt) 2008-12-30 2015-07-14 Nupathe Inc Controle eletrônico de sistema de distribuição de fármaco
EP2459184A1 (en) 2009-07-31 2012-06-06 The Brigham and Women's Hospital, Inc. Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
CN102612343B (zh) 2009-11-17 2015-11-25 C·R·巴德股份有限公司 包括锚定装置和标识部分的包覆模制的进入端口
AU2011237592B2 (en) 2010-04-08 2016-10-27 Emory University Substituted androst-4-ene diones
EP2643048A1 (en) 2010-11-23 2013-10-02 Nupathe Inc. User-activated self-contained co-packaged iontophoretic drug delivery system
USD682416S1 (en) 2010-12-30 2013-05-14 C. R. Bard, Inc. Implantable access port
USD676955S1 (en) 2010-12-30 2013-02-26 C. R. Bard, Inc. Implantable access port
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
EP2704726B1 (en) 2011-05-04 2018-10-31 Trustees of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
EP2543370A1 (en) 2011-07-06 2013-01-09 Georgia Health Sciences University Research Institute, Inc. Compositions and Methods for Treating Herpes Simplex Virus
US9243037B2 (en) 2011-11-10 2016-01-26 Trustees Of Boston College Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
DE102012203880A1 (de) 2012-03-13 2013-09-19 Robert Bosch Gmbh Funktionspflaster mit Sensor und Aktor
US9707339B2 (en) 2012-03-28 2017-07-18 Angiodynamics, Inc. High flow rate dual reservoir port system
US9713704B2 (en) 2012-03-29 2017-07-25 Bradley D. Chartrand Port reservoir cleaning system and method
DE102012205745A1 (de) * 2012-04-10 2013-10-10 Robert Bosch Gmbh Elektronische Pflastervorrichtung mit wenigstens einer Energiequelle
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US20150366890A1 (en) 2013-02-25 2015-12-24 Trustees Of Boston University Compositions and methods for treating fungal infections
CA2924141C (en) 2013-08-22 2022-06-07 The General Hospital Corporation 5-amino 4-cyano substituted oxazole and thiazole derivatives as inhibitors of human 12/15-lipoxygenase
EP3038625A4 (en) 2013-08-29 2017-08-23 Trustees of Boston University Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
US20150147555A1 (en) * 2013-11-23 2015-05-28 Orahealth Corporation Multilayer mucoadhering patch with a nonadhering layer comprising casein
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
CA2958747C (en) 2014-08-15 2022-08-16 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
EP3303286B1 (en) 2015-06-01 2023-10-04 Cedars-Sinai Medical Center Compounds that bind to rela of nf-kb for use in treating cancer
US10570152B2 (en) 2015-07-28 2020-02-25 Vyome Therapeutics Limited Antibacterial therapeutics and prophylactics
WO2017135474A1 (en) * 2016-02-05 2017-08-10 Nitto Denko Corporation Transdermal permeant application device
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US385556A (en) * 1888-07-03 Medicated electric belt
US486902A (en) * 1892-11-29 Galvanic body-battery
US770014A (en) * 1904-09-13 Electfiomedical
US351233A (en) * 1886-10-19 Henry w
US857664A (en) * 1907-01-10 1907-06-25 David R Overman Electromedical appliance.
US2301567A (en) * 1940-12-04 1942-11-10 Charles O Morse Allergen applicator and skin tester
US2667162A (en) * 1950-05-03 1954-01-26 Zwahlen Henry Device permitting the ambulatory ionization of blood circulatory troubles of the lower limbs
US2784715A (en) * 1953-03-25 1957-03-12 Kestler Otto Colman Cataphoresis unit
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4166457A (en) * 1976-08-16 1979-09-04 University Of Utah Research Institute Fluid self-sealing bioelectrode
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4856188A (en) * 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US5135479A (en) * 1983-08-18 1992-08-04 Drug Delivery Systems, Inc. Programmable control and mounting system for transdermal drug applicator
US5224928A (en) * 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4911688A (en) * 1986-07-15 1990-03-27 Patent Research And Development Corp. Fluid containing covers - with electrical circuits
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
US4997418A (en) * 1988-04-21 1991-03-05 C. P. Chambers Epidermal iontophoresis device
US5195953A (en) * 1988-04-21 1993-03-23 Demartini Richard J Method of increasing skin absorption of a drug
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
IT1244030B (it) * 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
US5047007A (en) * 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
WO1991015261A1 (en) * 1990-03-30 1991-10-17 Medtronic, Inc. Activity controlled electrotransport drug delivery device
US5037381A (en) * 1990-07-27 1991-08-06 Bock C Randolph Electrically assisted transdermal transport device and method for renewing the device
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
US5254081A (en) * 1991-02-01 1993-10-19 Empi, Inc. Multiple site drug iontophoresis electronic device and method
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
US5246418A (en) * 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
ATE190233T1 (de) * 1992-12-31 2000-03-15 Alza Corp Elektrotransporteinrichtung
US5458569A (en) * 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
FR2709670B1 (fr) * 1993-09-10 1995-10-20 Asulab Sa Dispositif en trois modules pour l'administration transdermique de médicaments par électrophorèse ou iontophorèse.
US5498235A (en) * 1994-09-30 1996-03-12 Becton Dickinson And Company Iontophoresis assembly including patch/controller attachment

Also Published As

Publication number Publication date
US5879322A (en) 1999-03-09
ZA962122B (en) 1996-09-26
PT817659E (pt) 2001-09-28
ATE201604T1 (de) 2001-06-15
GR3036450T3 (en) 2001-11-30
EP0817659A1 (en) 1998-01-14
WO1996030077A1 (en) 1996-10-03
DK0817659T3 (da) 2001-08-06
JPH11503037A (ja) 1999-03-23
DE69613113T2 (de) 2002-03-21
DE69613113D1 (de) 2001-07-05
EP0817659B1 (en) 2001-05-30

Similar Documents

Publication Publication Date Title
BR0205721A (pt) Formulações de oximorfona de liberação controlada
SE8405479D0 (sv) Sett att administrera flyktiga, fysiologiskt, aktiva emnen och anordning for detta
DE69613113D1 (de) Unhabhängige vorrichtung zur transdermalen verabreichung von medikamenten
ES2105897T3 (es) Dispositivo dosificador destinado a distribuir dosis constantes de un fluido contenido en un recipiente.
MXPA03011625A (es) Estacion de carnada para roedores.
IT1209447B (it) Dispositivo a luce di xeno per emettere spettri dell'ultravioletto e del visibile.
ES2144398T3 (es) Tratamiento mejorado de enfermedades autoinmunes mediante la administracion en aerosol de autoantigenos.
ES2000428A4 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
ES2127196T3 (es) Receptaculo impermeable a la nicotina y metodo para su fabricacion.
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
DK1434623T3 (da) Indretning til lægemiddelafgivelse ved intraokulær iontoforese eller elektroporation
ES2190430T3 (es) Nuevas sulfonamidas.
HN2001000012A (es) Tratamiento de la enfermedad neurodegenerativa
HRP20041152B1 (hr) Farmaceutske formulacije
UY27186A1 (es) Formulación farmacéutica
ES2162035T3 (es) Procedimiento para el aislamiento de galantamina.
DK1291021T3 (da) Farmaceutiske formuleringer som omfatter thyroideahormoner
ES2086079T3 (es) Tramadol n-oxido, enantiomeros y sus composiciones, y su utilizacion.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2098496T3 (es) Forma medicamentosa aplicable por via peroral para el tratamiento de estados de insuficiencia de dopamina en el sistema nervioso central.
UY25192A1 (es) Formulación medicamentosa con liberación controlada de sustancia activa
ES2016898A6 (es) Dispensador de colirios mejorado.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 817659

Country of ref document: ES